Meningismus Associated with Malpositioned Intraspinal Catheter for Drug Delivery

Background:  Implanted delivery systems for intrathecal drug administration have become more common in the management of nonmalignant pain. Many postprocedural complications have been described in the literature including infection and headache provoked by position changes. Determining the etiology of a postimplant headache is important particularly when considering the possibility of a life‐threatening infection.

[1]  S. Hassenbusch,et al.  Management of Intrathecal Catheter‐Tip Inflammatory Masses: An Updated 2007 Consensus Statement From An Expert Panel , 2008, Neuromodulation : journal of the International Neuromodulation Society.

[2]  T. Gan,et al.  Management of Persistent Postdural Puncture Headache After Repeated Epidural Blood Patch , 2008 .

[3]  Howard S. Smith,et al.  Intrathecal drug delivery. , 2008, Pain physician.

[4]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2007: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2007, Neuromodulation : journal of the International Neuromodulation Society.

[5]  T. Gan,et al.  Management of persistent post‐dural puncture headache after repeated epidural blood patch , 2007, Acta anaesthesiologica Scandinavica.

[6]  Williams Ko,et al.  New Onset Lumbar Radicular Pain After Implantation of an Intrathecal Drug Delivery System: Imaging Catheter Migration , 2006, Regional Anesthesia & Pain Medicine.

[7]  Gerhard Friehs,et al.  Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. , 2005, The journal of supportive oncology.

[8]  Thomas J. Smith,et al.  Pain management, including intrathecal pumps , 2004, Current oncology reports.

[9]  J. Drake,et al.  Prevention and Management of Intrathecal Drug Delivery and Spinal Cord Stimulation System Infections , 2004, Anesthesiology.

[10]  Thomas J. Smith,et al.  Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  L. Reik,et al.  Disorders that mimic central nervous system infections. , 1999, Neurologic clinics.

[12]  A. Koulousakis,et al.  Drug Adverse Events and System Complications of Intrathecal Opioid Delivery for Pain: Origins, Detection, Manifestations, and Management , 1999, Neuromodulation : journal of the International Neuromodulation Society.

[13]  E. Krames.  Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. , 1996, Journal of pain and symptom management.

[14]  P. Hardy.  Extradural blood patch of a cerebrospinal fluid cutaneous fistula in the presence of an intrathecal drug delivery system. , 1994, Anesthesiology.